Physician profile
Douglas E Lucas
NPI 1952537532
$67,590.08
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $11K · 2021: $15K · 2022: $2,651.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $43,557.09 | 2019-2021 | |
| Medical Device Business Services, INC. | $17,895.75 | 2020-2022 | |
| Wright Medical Technology, INC. | $3,547.17 | 2019 | |
| Depuy Synthes Products, INC. | $2,215.20 | 2019-2020 | |
| Paragon 28, INC. | $89.56 | 2019 | |
| Stryker Corporation | $76.57 | 2019 | |
| Medshape, INC. | $64.35 | 2019 | |
| Integra Lifesciences Corporation | $46.01 | 2019 | |
| Pacira Therapeutics, INC. | $30.21 | 2019 | |
| Kci USA, INC. | $15.01 | 2019 | |
| Djo, LLC | $14.74 | 2019 | |
| Nevro Corp. | $14.03 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.62 | 2019 | |
| Peerless Surgical INC. | $11.77 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.